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Abstract
Background: The S. cerevisiae carbamylphosphate synthetase – aspartate transcarbamylase
multifunctional protein catalyses the first two reactions of the pyrimidine pathway. In this organism, these
two reactions are feedback inhibited by the end product UTP. In the present work, the mechanisms of
these integrated inhibitions were studied.
Results: The results obtained show that the inhibition is competitive in the case of carbamylphosphate
synthetase and non-competitive in the case of aspartate transcarbamylase. They also identify the substrate
whose binding is altered by this nucleotide and the step of the carbamylphosphate synthetase reaction
which is inhibited. Furthermore, the structure of the domains catalyzing these two reactions were
modelled in order to localize the mutations which, specifically, alter the aspartate transcarbamylase
sensitivity to the feedback inhibitor UTP. Taken together, the results make it possible to propose a model
for the integrated regulation of the two activities of the complex. UTP binds to a regulatory site located
in the vicinity of the carbamylphosphate synthetase catalytic subsite which catalyzes the third step of this
enzyme reaction. Through a local conformational change, this binding decreases, competitively, the affinity
of this site for the substrate ATP. At the same time, through a long distance signal transmission process it
allosterically decreases the affinity of the aspartate transcarbamylase catalytic site for the substrate
aspartate.
Conclusion: This investigation provides informations about the mechanisms of allosteric inhibition of the
two activities of the CPSase-ATCase complex. Although many allosteric monofunctional enzymes were
studied, this is the first report on integrated allosteric regulation in a multifunctional protein. The positions
of the point mutations which specifically abolish the sensitivity of aspartate transcarbamylase to UTP define
an interface between the carbamylphosphate synthetase and aspartate transcarbamylase domains, through
which the allosteric signal for the regulation of aspartate transcarbamylase must be propagated.
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Background
Although numerous allosteric enzymes were studied,
much less information is available concerning the coordinated regulation of activities in multienzymatic complexes. Two feedback inhibited multienzyme complexes
were studied in Saccharomyces cerevisiae, the N-acetylglutamate synthase/N-acetyl glutamate kinase [1] and the carbamylphosphate synthetase – aspartate transcarbamylase
[2] complexes.
In procaryotes the first three reactions of the pyrimidine
biosynthetic pathway are catalyzed by independent
enzymes namely carbamylphosphate synthetase (CPSase,
EC 2.7.2.9), aspartate transcarbamylase (ATCase, EC
2.1.3.2), and dihydroorotase (DHOase, EC 3.5.2.3).
Escherichia coli CPSase is feedback inhibited by UMP [3]
and ATCase by CTP and UTP [4] (Figure 1). In contrast, in
mammals these three reactions are catalyzed by an hexameric 240-kDa multifunctional protein, the protein CAD,
made of covalently linked domains, each one catalyzing
one of these reactions [5-7]. In this case, only CPSase is
regulated, being feedback inhibited by UTP [8]. An interesting intermediary organisation is observed in S. cerevisiae. In this case a 240-kDa bifunctional protein encoded
by the URA2 locus possesses the CPSase and ATCase activities [2,9,10] but lacks the DHOase activity, although it
contains an inactive pseudo-DHOase (pDHO) domain
[10,11] homologous to the functional DHOases [5-7]. In
this organism both CPSase and ATCase are feedback
inhibited by UTP [12,13] (Figure 1). Similarly to what is
observed in CAD, this yeast multifunctional protein is
organized into four major functional domains:
-The glutaminase (GLNase) domain which hydrolyzes
glutamine and transfers ammonia to the carbamylphosphate synthetase domain [10].
-The CPSase domain which catalyzes the synthesis of carbamylphosphate from two molecules of ATP, bicarbonate
and ammonia in a stepwise fashion that involves three
partial reactions: the activation of bicarbonate by ATP, the
reaction of the activated species, carboxyphosphate, with
ammonia to form carbamate and the ATP-dependent
phosphorylation of carbamate to form carbamylphosphate [3,14]:
(1) ATP-Mg + HCO32-

-OCOOPO 2- +
3

ADP-Mg

-The ATCase domain which catalyzes the reaction of carbamylphosphate
and
aspartate
to
form
carbamylaspartate.
The N- and C-halves of CPSases from all organisms examined so far, show a significant degree of sequence similarity [10,15-20], an observation which was interpreted to
mean that the genes coding for these enzymes evolved
through a process of gene duplication, fusion, and differentiation [15,16]. The two domains corresponding to
these two halves are called CPS-A and CPS-B. Unexpectedly, it was discovered that each of these two domains of
the mammalian CAD CPSase are able to independently
catalyze the formation of carbamylphosphate provided
that they dimerize [21,22]. In the same way, a truncated
yeast bifunctional protein lacking the GLNase and CPS-A
domains (CBApD) was shown to possess the CPSase activity regulated by UTP [23]. In contrast, the ATCase domain
was no longer sensitive to this nucleotide, indicating that
the two catalytic activities are controlled by distinct mechanisms [23].
In order to identify amino acid residues implicated in the
feedback inhibition by UTP, genetics were used to positively select in vivo and characterize missense mutations in
the URA2 gene, which specifically affect the feedback –
inhibition of ATCase [24]. In these mutants ATCase is no
longer inhibited by UTP although CPSase retains full sensitivity to this effector, indicating again that UTP affects
the activities of CPSase and ATCase by different mechanisms [25].
In the present work the use of S. cerevisiae mutants in
which single amino acid replacements abolish the sensitivity of ATCase to UTP allowed to study specifically the
process of feedback inhibition of the CPSase domain by
this nucleotide. In addition, the reaction step affected by
the feedback inhibitor UTP was identified in both the
entire complex and in the truncated protein (CBApD).
Moreover a computational approach was used to predict
the structures of the CPSase and ATCase domains. The
results obtained provide informations about the integrated allosteric regulation of the two enzymatic activities
of the complex, and indicate that the regulatory site is
located in the CPS-B domain. The modelling defines an
interface between the CPSase and ATCase domains for the
transmission of the allosteric signal.

Results
(2) -OCOOPO32- + NH3 (Gln)
(3) NH2COO- + ATP-Mg
-The inactive pDHO domain.

NH2COO- + Pi +(Glu)
NH2COOPO32- +ADP-Mg

Inhibition of the CPSase and ATCase activities of the
complex
UTP inhibition of the coupled reaction
The influence of the feedback inhibitor UTP on the S. cerevisiae coupled CPSase-ATCase reaction catalyzed by the
complex was determined using the wild type complex
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regulatory properties of the enzymes catalyzing the first three reactions of the pyrimidine pathway
Organization and allosteric regulatory properties of the enzymes catalyzing the first three reactions of the
pyrimidine pathway in E. coli, S. cerevisiae and mammals. This scheme shows the functional domains that catalyze the
first steps in the de novo pyrimidine biosynthetic pathway, the amidotransferase or glutaminase domain (GLNase), the CPSase
synthetase domain consisting of two subdomains (CPS-A and CPS-B), the dihydroorotase domain (DHOase), and the ATCase
domain. The activities are associated with separate polypeptide chains in E. coli, whereas in mammals (CAD) all are consolidated on a single multifunctional protein. In yeast, the CPSase and ATCase domains are carried by a single polypeptide, but in
this case the active DHOase that is encoded by a separate gene is replaced with an inactive DHOase homologue (pDHO).
Eucaryotes ATCases lack the regulatory subunit (Reg) found in the E. coli protein. The scheme also shows the allosteric effectors that regulate the activity of these proteins and the localization of the regulatory sites represented by arrows.

present in the URA2-EK1104 strain, and is shown in Figure 2. Under the conditions used, complete inhibition is
observed for UTP concentrations superior to 3 mM, and
half inhibition of the overall reaction is observed in the
presence of 0.8 mM. The specific inhibition by UTP of
each of the two individual reactions was then investigated.
UTP inhibition of ATCase
The ATCase activity of the complex can be specifically
tested without interference of the CPSase activity by providing carbamylphosphate and aspartate to the complex.

The influence of UTP on this activity was determined
using the same strain than above. The result obtained is
shown in Figure 3. Complete inhibition cannot be
obtained and under the conditions used (50 mM aspartate) one observes a 20% residual activity. Similar results
were previously reported [12,25,26], the value of the plateau of inhibition varying with the aspartate concentration [26]. Such a pattern is characteristic of a process of
partial competitive inhibition in which the binding of the
inhibitor to a site distinct from the catalytic site decreases
the affinity of the active site for the substrate through a
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of the S. cerevisiae CPSase-ATCase coupled reaction
UTP inhibition of the S. cerevisiae CPSase-ATCase coupled reaction. The influence of UTP on the coupled CPSaseATCase reaction was determined as indicated in the Methods using the dialyzed crude extract of the E. coli EK1104 strain
transformed by pC4-URA2, in the presence of 50 mM aspartate.

conformational change. This result is consistent with the
previously reported observation that towards carbamylphosphate the inhibition by UTP is of uncompetitive type
[26].
UTP inhibition of CPSase
Since the CPSase assay involves its coupled reaction with
ATCase, in order to study specifically the influence of the
feedback inhibitor on the CPSase reaction, it was necessary to use mutants in which the ATCase reaction is insensitive to this effector. Such mutants were previously
described [25] and it was shown that this specific desensitization could result from single missense mutations
located either in the ATCase domain or in the CPSase
domain of the complex [25]. Three of these mutants were
used in this study: Asn1094→Asp located in the CPSase
domain; Glu1933→Lys and Glu2182→Lys located in the
ATCase domain [25] (Table 1). Complete inhibition of
the CPSase reaction by UTP was observed in the three
cases, in accordance with the complete inhibition of the
coupled reaction reported above. In order to investigate
the nature of this inhibition and to identify the substrate(s) whose binding or utilization is altered by the
effector, the influence of UTP was measured in the pres-

ence of varying concentrations of the three substrates of
CPSase: ATP, glutamine, and bicarbonate. The three
mutants provide the same results which are presented
here in the case of Glu2182→Lys. These results are shown
in Figure 4, where double reciprocal plots are presented
on the left, and Dixon plots on the right. Taken together,
these results show unambiguously that UTP acts as a competitive inhibitor towards ATP and as a non competitive
inhibitor towards bicarbonate and glutamine, a pattern
which indicates that UTP acts by decreasing specifically
the apparent affinity of the catalytic site for ATP with a KI
of 3 ± 1 mM. These results indicate a process of absolute
competitive inhibition toward ATP.
The UTP inhibition curves of the complexe and of the
individual CPSase and ATCase reactions exhibit a slight
cooperativity with a Hill number of 1.2 ± 0.1. This is
shown in Figure 5 in the case of the Glu2182→Lys
mutant.
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of the S. cerevisiae ATCase reaction of the CPSase-ATCase complex
UTP inhibition of the S. cerevisiae ATCase reaction of the CPSase-ATCase complex. The influence of UTP on the
ATCase reaction of the bifunctional complex was determined as indicated in the Methods in the presence of 50 mM aspartate
and 10 mM carbamylphosphate using dialyzed crude extract of the E. coli EK1104 strain transformed by pC4-URA2.

Determination of the CPSase reaction step influenced by
the feedback inhibitor UTP
Wild type complex
As indicated in the Background section, the reaction catalyzed by CPSase is complex and consists in three partial
reactions. Two of them involve a molecule of ATP and
these two steps, (1) and (3), can be specifically tested: step
(1) on the basis of the bicarbonate dependent ATP/ADP
exchange and step (3) in the presence of carbamylphosphate and ADP measuring the ATP production using a
coupled reaction with hexokinase and glucose 6-phosphate dehydrogenase (see Methods). The influence of
UTP on these two partial reactions was investigated and
the results obtained are shown in Figure 6, which shows
clearly that it is strictly the third partial reaction catalyzed
by the CPS-B domain, which is specifically inhibited by
UTP.
CBApD mutant
In the CBApD mutant it is a dimer of CPS-B domain (see
Background and Fig. 7a) which catalyzes the three steps of
the CPSase reaction [23]. Since in the wild type complex
it is only the CPS-B domain which is sensitive to UTP, it
was interesting to determine whether in this mutant the

step 1 catalyzed by this domain becomes also sensitive to
the feedback inhibitor. Thus, the putative influence of
UTP on the partial reaction 1 was investigated in comparison with the partial reaction 1 catalyzed by CPS-A in the
wild type complex. The results obtained are shown in Figure 7b were it appears that in this mutant, both steps 1
and 3 are feedback inhibited by UTP, indicating that the
regulatory site for UTP is effective for the inhibition of
step 1 when catalyzed by the CPS-B where it is located.
This observation is consistent with the lack of a regulatory
site in the CPS-A domain [27,28].
Modelling of the CPSase and ATCase domains and
localization of the missense mutations affecting the
sensitivity of ATCase to UTP
Amino acid sequences alignment
In order to model the CPSase domain of the complex, we
used FASTP to compare the amino acid sequences of E.
coli CPSase and the S. cerevisiae CPSase domain of the
CPSase-ATCase complex (Fig. 8). These two homologous
proteins have approximately the same size, and show very
similar sequences with few insertions and deletions. The
degree of identity between the E. coli enzyme (residues 2–
1073) and the yeast CPSase domain (434–1502) is 42%.
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Figure 4 saturation curves of the CPSase from the mutant Glu 2182→Lys in presence or absence of UTP
Substrate
Substrate saturation curves of the CPSase from the mutant Glu 2182→Lys in presence or absence of UTP. The
CPSase activity was measured as indicated in the Methods. On the left are represented the double reciprocal plots in the presence of (●) 0 mM, (◆) 3 mM, and (■) 6 mM UTP. On the right are presented the corresponding Dixon plots. The concentrations used were (●) 6.7 mM, (◆) 9.3 mM, (■) 10.7 mM, and (❍) 33 mM in the case of ATP; (●) 2.1 mM, (◆) 5.3 mM, (■) 7.5
mM, and (❍) 20 mM in the case of bicarbonate; (●) 0.03 mM, (◆) 0.07 mM, (■) 0.3 mM, and (❍) 1 mM in the case of
glutamine.
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Table 1: Position of the missense mutations affecting the
sensitivity of ATCase to UTP.

Mutants

Domain

Arg1076 →Ser
Asn1094 →Asp
Tyr1096 →Cys
Trp1112 →Leu
Asp1220 →Tyr

CPSase

Phe1924 →Val
Glu1933 →Lys
Glu1933 →Gly
Glu2052 →Lys
Gly2055 →Ser
Asn2058 →Asp
Asn2157 →Lys
Glu2182 →Lys
Asp2186 →Asn

ATCase

All the mutants carry missense mutations leading to a single amino
acids replacement. Five of them are located in the CPSase domains
while the others are in the ATCase domain. In these mutants,
ATCase is no longer inhibited by UTP although CPSase retains full
sensitivity to this effector.

This alignment involves 10 small deletions and 6 insertions in the yeast sequence (Fig. 8). None of these insertions and deletions occur in highly conserved regions or
within regions of well-defined secondary structure (not
shown). Moreover, all the amino acid residues of the catalytic site which were identified in the X-ray structure of
the E. coli CPSase are conserved in the yeast sequence. The
same method was used to align the sequences of the
ATCase domain of the S. cerevisiae complex and the
ATCase catalytic chain of E. coli. The result obtained is
identical to that previously reported from the use of the
Needleman and Wunsch algorithm [29,30]. The degree of
identity is 42% and that involves the presence of 4 minor
deletions and 3 insertions. Here also all the amino acid
residues which were previously shown to interact with the
substrates in the catalytic site of E. coli ATCase are present
in S. cerevisiae [30,31].
Modelling of the S. cerevisiae CPSase and ATCase domains
The similarity of the S. cerevisiae CPSase domain and the
E. coli CPSase in sequence and kinetic properties
prompted us to model the structure of this yeast domain
using the X-ray coordinates of the E. coli CPSase [32] as a
tertiary template as indicated in Methods. The model
obtained is shown as a Swiss-PdbViewer representation in
Figure 9. It appears clearly that these two structures are
very similar. In the same way and for the sake of homogeneity, the same procedure was used to model the S. cerevisiae ATCase domain on the basis of the cristallographic
structure of the homologous E. coli enzyme [33]. Again,

the two structures appear to be strikingly identical (not
shown) in accordance with the observation previously
made using a different procedure [30].
Localization of the ATCase desensitizing mutations
As reported above a series of missense mutants of the S.
cerevisiae complex were obtained in which the ATCase
activity is insensitive to the feedback inhibitor UTP, the
CPSase activity remaining fully sensitive to this nucleotide
[25]. Interestingly, these point mutations are located
either in the ATCase or in the CPSase domains (Table 1).
Thus, it was of interest to localize these point mutations in
the modelled structures of the two domains. The result is
shown in Figure 10. Most interestingly, it appears that
these mutants are clustered in a particular region of the
surface of the two domains, suggesting that these two
regions constitute an interface between the two domains,
through which the regulatory signal from the allosteric
UTP binding site located in the CPSase domain to the catalytic site of the ATCase domain should be transmitted.
However one of these mutations (Phe1924→Val) is
located close to the catalytic site of ATCase suggesting that
this residue would be rather involved in the transmission
of the regulatory signal from the interface to the ATCase
catalytic site.

Discussion
In the S. cerevisiae CPSase-ATCase complex the two activities are feedback inhibited by the end-product UTP
[12,13]. In the case of CPSase, the results reported here
indicate that the substrate whose binding is altered by this
effector is ATP as shown previously in the case of E. coli
CPSase [34]. In the case of yeast ATCase, UTP decreases
the affinity for the substrate aspartate [26]. Taken together
with previously published observations, the results
reported here show that the feedback inhibition of the
yeast complex is of absolute competitive nature in the case
of CPSase and of partial competitive nature in the case of
ATCase. This last behavior is characteristic of a process of
allosteric inhibition in which the effector binds to a regulatory site distinct from the catalytic site. In the case of
CPSase the absolute competition indicates that UTP binds
close enough to directly prevent the binding of ATP to this
site through a local conformational change.
Several lines of evidence show that the regulatory site
where UMP (procaryote CPSases) or UTP (enkaryote
CPSases) binds is localized in the B3 subdomain (Fig. 1)
[27,28,35]. Among the two steps of the CPSase reaction
which, each, use a molecule of ATP (steps 1 and 3) only
the third one is inhibited by UTP (Fig. 6). This partial reaction is specifically catalyzed by the B2 subdomain. Thus,
it appears that the UTP binding site is located in the CPSB domain which catalyzes the partial reaction which is
specifically inhibited by this nucleotide, a feature which
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curve of the CPSase from the mutant Glu 2182→Lys
UTP inhibition curve of the CPSase from the mutant Glu 2182→Lys. The percentage of inhibition by UTP was tested
under the standard conditions as indicated in the Methods in the presence of increasing concentrations of UTP. The kinetic
data were fit to the Hill equation :

( % of inhibition )max ⋅ ( UTP )nH
v=
( KI )nH + ( UTP )nH

relates to the absolute competitive inhibition reported
above. In the E. coli enzyme this regulatory site and the
CPS-B catalytic site are distant by approximately 20 Å
[36]. However, in the yeast complex this distance might
be lower as the result of interactions with the ATCase and
pDHOase domains. Alternatively, UTP might act through
a different mechanism in the yeast complex and might
provoke the competitive inhibition through binding to
the CPS-B ATP binding site.
The first partial reaction catalyzed by the domain A is not
affected by the presence of UTP. It was shown previously
that the dimer of the isolated B domain is able to catalyze
the synthesis of carbamylphosphate [23]. Interestingly, in
this case, the first step of the CPSase reaction becomes sensitive to UTP (Fig. 7). Thus, the reaction normally catalyzed by the A domain becomes sensitive to UTP when it

is catalyzed by the B domain which contains the allosteric
UTP binding site. Taken together, these observations
indicate that although it is homologous to the B3 domain,
the A3 subdomain is unable to bind UTP.
As far as the feedback inhibition of the ATCase activity is
concerned, several lines of evidence show that the presence of the CPSase domain of the S. cerevisiae complex is
necessary for the ATCase domain to be sensitive to UTP,
and that a single UTP binding site is located in the CPSase
domain. Separation of the CPSase and ATCase domains
by limited proteolysis [37] or genetic engeneering [2325,38] leads to the desensitization of the ATCase domain.
Taken together with the results reported here concerning
the partial competitive character of the ATCase feedback
inhibition, the requirement of the CPSase domain
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Figure 6 of UTP on the partial reactions 1 and 3 of the CPSase reaction of the wild type complex
Influence
Influence of UTP on the partial reactions 1 and 3 of the CPSase reaction of the wild type complex. The influence
of UTP on steps 1 and 3 was determined as indicated in the Methods using dialyzed crude extract of the E. coli EK1104 strain
transformed by pC4-URA2. (●) partial reaction 1, and (■) partial reaction 3.

strongly suggests that the CPSase and the ATCase catalytic
sites are both under the influence of the UTP binding regulatory site located in the B3 subdomain.

domain of one activity is the allosteric site for the other
activity.

Methods
Conclusions
The results obtained provide informations about the
mechanisms of allosteric inhibition of the two activities of
the CPSase-ATCase complex. It is of particular interest that
the mutations which specifically abolish the sensitivity to
UTP of the ATCase reaction, without altering the CPSase
inhibition, are clustered on the surface of either the CPSB domain or the ATCase domain. This observation
strongly suggests that these two regions constitute the
interface between the two domains, interface through
which the regulatory signal must be transmitted from the
CPSase regulatory site to the catalytic site of the ATCase
domain. This transmission could involve either a specific
path between this interface and the catalytic site of
ATCase, or a more global conformational change of this
ATCase domain leading to a decrease of the affinity of this
site for aspartate.
This is an original example of integrated allosteric regulation in a multifunctional complex that the catalytic

Plasmids and strains
The 14.0-kb plasmid pC4-URA2 contains the yeast ura2
gene encoding the bifunctionnal CPSase-ATCase complex
[25]. The pSV-CBApD recombinant plasmid encodes a
protein CBApD, that possesses the C-terminal half of
CPSase (CB), linked to the pDHO (pD) and the ATCase
(A) domains [23].

The S. cerevisiae LJ5 strain was transformed by pC4 carrying a wild-type or mutated ura2 allele [25]. The LJ5 recipient strain was chosen because it is devoid of endogenous
CPSase and ATCase activities.
The E. coli mutant L673 strain [39], defective in carA and
carB, as well as the Lon-protease, was a gift from Dr. Carol
Lusty (Public Health Research Institute of the City of New
York). The genes carA and carB encode the small and large
subunits of E. coli carbamoyl phosphate synthetase,
respectively. The E. coli host strain EK1104 [40] lacks the
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on the partial reactions 1 and 3 of the CPSase reaction catalyzed by CBApD
Figure
7
UTP influence on the partial reactions 1 and 3 of the CPSase reaction catalyzed by CBApD. (a) The truncated
complex CBApD possess CPS-B, pDHO and ATCase domains. (b) The influence of UTP on steps 1 and 3 was determined as
indicated in the Methods using dialyzed crude extract. (●) partial reaction 1, and (■) partial reaction 3.

pyrB1 genes. E. coli EK1104 and L673 cells were transformed with pC4-URA2 and pSV-CBApD respectively.
Cell growth and preparation of cell-free extracts
S. cerevisiae LJ5 strain harboring the recombinant plasmids was grown on YNB (6.7 g yeast nitrogen base / 1.2%
glucose) at 30°C. Supplements were added to a 50 mg/ml
final concentration. E. coli EK1104 and L673 cells
harboring the recombinant plasmids were routinely
grown from a single colony in 2xYT media supplemented
with 100 µg/ml ampicillin. For induction of recombinant
proteins under control of the pyrB1 promoter, the EK1104
and L673 cells were grown in a minimal media consisting
of 6 g/l Na2HPO4, 3 g/l KH2PO4, 1 g/l NH4Cl, 5 g/l
casamino acids, 4 g/l glucose, 0.5 mg/l ZnSO4.7H2O, 0.1
mM CaCl2, 1 mM MgSO4.7H2O, 10 mg/l tryptophan, supplemented with 12 µg/ml uracil and 100 µg/ml ampicillin. Under these conditions, there is sufficient uracil to
sustain growth for about 19 to 21 hours, after which time,
uracil is exhausted, growth is slowed, and the recombinant protein is expressed. Growth was monitored spectrophotometrically at 600 nm. The cells were harvested in
late exponential phase or early stationary phase, by centrifugation at 3000 g for 30 minutes in a Centrikon T-124

centrifuge. The cells were resuspended in 50 mM Tris-HCl
(pH 7.5), 1 mM EDTA, 1 mM DTT, and disrupted by sonication three times for one minute on ice, using a Biosonik
III sonifier set at 20,000 kHz. The sonicate was cleared by
centrigugation at 12,000 g for 30 minutes at 4°C. These
extracts were dialyzed in order to eliminate all the metabolites, including nucleotides, which might interfere with
enzyme assays. Protein concentrations were assayed by
the Lowry method [41].
Enzymatic activities
Enzymatic activities were tested on crude dialyzed extracts
as described by Penverne & Hervé [26]. The ATCase activity was tested as described by Denis-Duphil et al. [37]. The
standard conditions used were 30 mM (14C)aspartate
(0.03 µCi/µmol), 10 mM carbamylphosphate, and 50
mM Tris-HCl, pH 7.5. The assays were conducted at 30°C
for 10 minutes. The CPSase activity of the yeast CPSaseATCase and the CBApD complexes were assayed in the
presence of 5 µg of E. coli ATCase catalytic subunits to
efficiently trap all the unstable carbamylphosphate
formed. The standard conditions used were 50 mM TrisAc, pH 7.5, 100 mM KCl, 100 mM NH4Cl, 150 mM
(14C)sodium bicarbonate (0.168 µCi/µmol), 20 mM magPage 10 of 15
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CARB-E
PYR1-Y

1
4 06

MPKRTDI KSI LIL GAGPI VI GQACEFDYSGAQA
Q AVKEFKYTQVLKPI AFP GGLLEDNVKAHPRI EAKKVLVLGSGGLSI GQAGEFDYSGSQA

CARB-E
PYR1-Y

34
4 66

CKALREEGYRVI LVNSNPATI MTDPEMADATYI EPI HWEVVRKI I EKERPDAVLPTMGGQ
I KALKEEGI YTI LI NPNI ATI QTSKGLADKVYFVPVTAEFVRKVI LHERPDAI YVTFGGQ

CARB-E
PYR1-Y

94
5 26

TALNCALELERQGVLEEFGVTMI GATADAI DKAEDRRRFDVAMKKI GLETARSGI AHTME
TALSVGI AMKDE- - FEALGVKVLGTPI DTI I TTEDRELFSNAI DEI NEKCAKSQAANSVD

CARB-E
PYR1-Y

1 54
5 84

EALAVAADVGFPCI I RPSFTMGGSGGGI AYNREEFEEI CARGLDLSPTKELLI DESLI GW
EALAAVKEI GFPVI VRAAYALGGLGSGFANNEKELVDLCNVAFSSSP- - QVLVEKSMKGW

CARB-E
PYR1-Y

2 14
6 42

KEYEMEVVRDKNDNCI I VCSI ENFDAMGI HTGDSI TVAPAQTLTDKEYQI MRNASMAVLR
KEVEYEVVRDAFDNCI TVCNMENFDPLGI HTGDSI VVAPSQTLSDEDYNMLRTTAVNVI R

CARB-E
PYR1-Y

2 74
7 02

EI GVETGGSNVQFAVNPKNGRLI VI EMNPRVSRSS ALASKATGFP I AKVAAKLAVGYTLD
HLGV- VGECNI QYALNPVSKDYCI I EVNARLSRSS ALASKATGYPLAYTAAKLGLNI PLN

CARB-E
PYR1-Y

3 34
7 61

ELMNDI TGGRTPASFEPSID YVVTKI PRFNFEKFAGANDRLTTQMKSVGEVMAIG RTQQE
EVKNSVTKS- TCACFEPSLDYCVVKMPRWDLKKFTRVSTELSSSMKSVGEVMSIG RTFEE

CARB-E
PYR1-Y

3 94
8 20

SLQKALRGLEVGATGFDPKVSLDDPEALTKI RRELKDAGADRI WYI ADAF- RAGLSVDGV
AI QKAI RSTEYANLGFN- ETDLD- - - - -I DI DYELNNPTDMRVFAI ANAFAKKGYSVDKV

CARB-E
PYR1-Y

4 53
8 74

FNLTNI DRWFLVQI EELVRLEEKVAEVGI TG- LNADFLRQLKRKGFADARLAKLAGVREA
WEMTRI DKWFLNKLHDLVQFAEKI SSFGTKEELPSLVLRQAKQLGFDDRQI ARFLDSNEV

CARB-E
PYR1-Y

5 11
9 34

E I RKLRDQYDLHPVYKRVDTCAAEFATDTAYMYSTYEEECEANPSTDREKI MVLGGGPNR
A I RRLRKEYGI TPFVKQI DTVAAEFPAYTNYLYMTYNADSH- DLSFDDHGVMVLGSGVYR

CARB-E
PYR1-Y

5 72
9 93

I GQGIE FDYCCVHASLALREDGYETI MVNCNPETVSTDYDTSDRLYFEPVTLEDVLEI VR
I GSSVEFDWCAVTAVRTLRANNI KTI MVNYNPETVSTDYDEADRLYFETI NLERVLDI YE

CARB-E
PYR1-Y

6 32
1 053

I EKPKGVI VQYGGQTPLKLARALEAAGVPVI GTSP DAI DRAEDRERFQHAVERLKLKQPA
I ENSSGVVVSMGGQTSNNI AMTLHRENVKI LGTSP DMI DSAENRYKFSRMLDQI GVDQPA

CARB-E
PYR1-Y

6 92 N ATVTAI EMAVEKAKEI GYPLVVRPSYVLGGRAMEI VYDEADLRRYFQTAVSVSNDAPVL
1 113 W KELTSMDEAESFAEKVGYPVLVRPSYVLSGAAMNTVYSKNDLESYLNQAVEVSRDYPVV

CARB-E
PYR1-Y

7 52
1 173

CARB-E
PYR1-Y

8 11 Q QVQKLAFELQVRGLMNVQFAVKNNEVYLI EVNPRAARTVPFVSKATGVPLAKVAARVMA
1 232 V ATAKI GKALKI TGPYNI QFI AKDNEI KVI ECNVRASRSFPFI SKVVGVNLI ELATKAI M

CARB-E
PYR1-Y

8 71
1 292

GKSLAEQGVTKEVI PP- YYSVKEVVLPFNKFPGVDPLLGPEMRSTGEVMGVGRTFAEAFA
GLPLTPYPVEK- - LPDDYVAVKVPQFSFPRLAGADPVLGVEMASTGEVATFGHSKYEAYL

CARB-E
PYR1-Y

9 30
1 350

KAQLGSNSTMKKHGRALLSV- REGDKERVVDLAAKLLKQGFELDATHGTAI VLGEAGI NP
KSLLATGFKLPKKN- I LLSI GSYKEKQELLSSVQKLYNMGYKLFATSGTADFLSEHGI AV

CARB-E
PYR1-Y

9 89
1 409

R- - - LVNKVHEGRPH- - - I QDRI KNGEYTYI I NTTSGRRAI EDSRVI - - - - -- RRSALQY
QYLEVLNKDDDDQKSEYSLTQHLANNEI DLYI NLPSANRFRRPASYVSKGYKTRRLAVDY

CARB-E
PYR1-Y

1 037
1 469

KVHYDTTLNGGFATAMALNADATEKVI SVQEMHAQI K
SVPLVTNVKCAKLLI EAI SRNI T- - - LDVSERDAQTS …

LDHFLDDAVEVDVDAI C- DGEMVLI GGI MEHI EQAGVHSGDSACSLPAYTLSQEI QDVMR
I TKYI ENAKEI EMDAVARNGELVM- HVVSEHVENAGVHSGDATLI VPPQDLAPETVDRI V

*

*

Sequence
Figure 8 alignment of the CPSase(s) from E. coli and S. cerevisiae
Sequence alignment of the CPSase(s) from E. coli and S. cerevisiae. The amino acids sequences of the CPSase(s) from
E. coli and S. cerevisiae were aligned as indicated in the Methods. CARB-E : E. coli; PYR1-Y: S. cerevisiae. ([ ]), limits of the
sequence used for the modeling process. (↑), limit between A and B domains. (◆), point mutations which abolish the sensitivity
of the ATCase domain to UTP (see table 1). (*) lysine992 and serine948 residues located in the UMP binding site of the E. coli
CPSase.
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Figure
Modelled9 structure of the S. cerevisiae CPSase domain of the CPSase-ATCase complex
Modelled structure of the S. cerevisiae CPSase domain of the CPSase-ATCase complex. Top: cristallographic
structure of the E. coli CPSase [32]. Bottom: modelled structure of the S. cerevisiae CPSase domain of the bifunctional protein
obtained as indicated in the Methods. The CPS-A and CPS-B domains are in green and light-green respectively. The two catalytic subsites of the E. coli CPSase are indicated by two molecules of ADP. Lysine992 and serine948 located in the UMP binding
site of the E. coli CPSase are in magenta.
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Probable
Figure 10
interface between the CPSase and ATCase domains of the S. cerevisiae bifunctional complex
Probable interface between the CPSase and ATCase domains of the S. cerevisiae bifunctional complex. In green:
the yeast CPSase domain. In red: the yeast ATCase domain. In yellow: point mutations which specifically abolish the sensitivity
of the ATCase activity to UTP (see Table 1). From top to bottom: Asp1220, Trp1112, Tyr1096, Asn1094, Arg1076 in the
CPSase domain; Glu1933, Glu2052, Phe1924, Asn2058, Asp2186, Glu2182, Asn2157 in the ATCase domain. The CPSase catalytic subsites are indicated by two molecules of ADP.
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nesium acetate, 10 mM ATP, and 50 mM aspartate. The
assays were conducted at 30°C for 30 minutes. The
extracts samples were extensively dialyzed immediately
before the enzymatic tests in order to eliminate all the
metabolites (including nucleotides) potentially able to
interfere with the activities.
The overall carbamylphosphate synthetase – aspartate
transcarbamylase activity was tested as described by Penverne et al. [42] without the addition of E. coli ATCase
catalytic subunits. The partial reaction 1 of CPSase was
assayed at 25°C by coupling the production of MgADP to
the oxydation of NADH through the inclusion of pyruvate
kinase, PEP, and lactate dehydrogenase in the assay mixture. Disappearance of NADH was followed continuously
by monitoring the decrease in absorbance at 340 nm with
a strip chart recorder. Each cuvette contained in a final
volume of 1.0 ml the following: 50 mM Tris-Ac, pH 7.5,
100 mM KCl, 20 mM MgCl2, 0.2 mM NADH, 1 mM PEP,
50 mM NaHCO3, 10 mM L-glutamine, 10 mM MgATP,
0.1 mg of pyruvate kinase, and 0.15 mg of lactate dehydrogenase. The inhibitor UTP, if present, was 10 mM. The
reaction was started with the addition of 100 µl of
dialyzed crude extract. The partial reaction 3 of CPSase
was measured at 25°C by coupling MgATP production
with the reduction of NADP with hexokinase, glucose,
and glucose-6-phosphate dehydrogenase. All cuvettes
contained 50 mM Tris-Ac, pH 7.5, 100 mM KCl, 20 mM
MgCl2, 1 mM NADP, 10 mM glucose, 1 unit each of hexokinase and glucose-6-phosphate dehydrogenase, 6 mM
of MgADP (≈ Km), and 10 mM carbamoyl phosphate. The
inhibitor UTP, if present, was 10 mM. The reaction was
started by the addition of 100 µl of dialyzed crude extract.
It was verified that the CPSase reaction was fully
dependent on the presence of the three substrates. In the
case of the L673 strain these controls were already published [23]. The same full requirement was observed in
the case of the EK1104 strain. The bicarbonate ATPasedependent reaction was undetectable in absence of
bicarbonate.
Assay for UTP inhibition
The sensitivity of CPSase and ATCase to the feedback
inhibitor UTP was assayed under the standard conditions
described above in the presence of varying concentrations
of this effector.

http://www.biomedcentral.com/1471-2091/5/6

Homology modelling of the S. cerevisiae CPSase and
ATCase domains
The three-dimensional structure of the S. cerevisiae CPSase
and ATCase domains were modelled by comparative protein modelling methods and energy minimization using
the program SWISS-MODEL [43] in the optimized mode.
The 2.10 Å coordinate set for the CPSase from E. coli [32]
was used as the template for modelling the yeast CPSase
monomer. The 2.5 Å structure of the E. coli ATCase
complexed with the bisubstrate analogue N-(phosphonoacetyl)-L-aspartate [33] was used as the template for
modelling the yeast ATCase monomer. Swiss-PdbViewer
3.5 [43] was used to analyse and visualize the structures.

List of abbreviations
The abbreviations used are: CPSase, carbamylphosphate
synthetase; ATCase, aspartate transcarbamylase; GLNase:
glutamine amidotransferase; DHOase, dihydroorotase;
pDHO, the yeast domain that exibits sequence similarity
to functional DHOases but which lacks activity; CBApD,
the truncated yeast complex consisting of the CPS-B
domain fused to the ATCase domain via the pDHO
domain; CPS-A, the subdomain corresponding to the
amino half of the CPSase synthetase domain or subunit;
CPS-B and CB, the subdomain corresponding to the carboxy half of the CPSase synthetase domain or subunit.
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